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Aswedevelop content forCell StemCell, we strive to present an international view of the progress of stem cell research.We
also aim to serve as a forum for published interaction among stem cell scientists and related professionals who seek to
understand biological and pathological processes, and to develop improved diagnostic and therapeutic tools. These are
also central mandates of the ISSCR, and the current president, George Daley, outlines some of the new Society projects
designed with such goals inmind. Even the California Institute for RegenerativeMedicine is developing an international per-
spective; the incoming president is Australian Alan Trounson, and some of his visions for the CIRM are outlined in a Profile
article in this issue.
Symmetries and Asymmetries
The majority of introductory diagrams depicting stem cell division indicate two possible
daughter cell fates: a differentiated daughter or a self-renewing stem cell, identical to the pre-
mitotic mother cell. This pervasive dogma assumes that stem cells not only have the defined
potential to produce differentiated progeny and to self-replicate, but are also capable of gen-
erating both cell types in a single ‘‘asymmetric’’ division. While logical in principle, relatively
little data exist to support thismodel inmany cell types. In this issue, however, the laboratories
of Reya and Gage provide independent evidence for asymmetric cell divisions in blood or
brain precursors, respectively. Notably, the two groups demonstrate that the relative fre-
quency of the asymmetric divisions can be influenced by extrinsic signals, providing support
for the model that the type of stem cell division may be modulated by the situational demand
for more primitive or more differentiated cell progeny. The specific systems developed by both groups represent valuable
tools for continued examination of stem cell regulation in these and other cell types.
ES Cells from All Directions
When asked, most people agree that challenges are best tackled frommultiple angles, especially when the exact nature of
the problem is unknown. A range of articles in this issue highlight this concept as applied to the conduct of embryonic stem
cell research. A Correspondence article fromCook and colleagues describes a series of human ES cell lines generated with
therapeutic applications in mind. These pairs of lines permit treatment development using research-grade cells, while clin-
ical applications will be carried out using matched lines produced according to good manufacturing practices. Beyond de-
veloping appropriate culture conditions, many believe that access to human oocytes will be prohibitive in the derivation of
future hES cell lines via SCNT. As recently debated and approved, at least in principle, by the UK, an alternative may be the
use of nonhuman oocytes. A practice abhorred by some, interspecies nuclear transfer has a long and established history,
and has been reviewed in the issue by Cibelli and colleagues. ES cell research is also widely touted as a powerful tool for
studying various diseases, especially those of early development. In a groundbreaking study in this issue, Benvenisty’s lab
used surplus embryos from an IVF procedure that were identified by preimplantation genetic diagnosis to be predisposed
to fragile X syndrome. The resulting hES cell line affords an unprecedented view into the molecular pathology of this
disease, and highlights the potential inherent in this screening approach to ES cell research.
A Needle in a Haystack
The volume of literature identifying stem cells for various cancers continues to pour forth.
Indeed, this issue includes a paper from the Dontu lab indicating that ALDH1 activity
can be used to isolate a tumor-initiating population from human breast cancer samples.
Strikingly, cell selection that combines this trait with the expression of several estab-
lished cell surface markers yields a population with extremely high-frequency cancer
stem cell activity. This finding echoes the hematopoietic cell ‘‘fingerprint’’ Resource by
Goodell and colleagues, also in this issue, and highlights that while rare single markers
that correlate with primitive function may exist, combinations of genes and proteins may
better define complex populations. Importantly, the blood precursor fingerprinting ap-
proach may help identify functional regulators, or even oncogenes, through its potential
to recognize aberrant patterns in primitive precursor populations. Furthermore, the impli-
cations of the expanding range of cancers at least influenced by, if not due to, stem-like
populations on the diagnostic and therapeutic strategies employed by physicians are
discussed in this issue’s Commentary by Jean Wang. Coming full circle, ALDH1 activity may offer an important tool to
improve the accuracy of breast cancer prognoses, and perhaps will be extended to other tumor types as well.Cell Stem Cell 1, November 2007 ª2007 Elsevier Inc. xiii
